SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-21-001141
Filing Date
2021-08-10
Accepted
2021-08-09 20:00:24
Documents
1
Group Members
DRW COMMODITIES, LLCDRW HOLDINGS, LLCDRW INVESTMENTS, LLC

Document Format Files

Seq Description Document Type Size
1 e620855_sc13ga-aptose.htm SC 13G/A 93997
  Complete submission text file 0001193805-21-001141.txt   95717
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Subject) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49893 | Film No.: 211158013
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 540 W. MADISON ST., SUITE 2500 CHICAGO IL 60661
Business Address
Wilson Donald R. Jr. (Filed by) CIK: 0001565352 (see all company filings)

Type: SC 13G/A